Pendrin is an anion exchanger expressed in the apical regions of B and non-A, non-B intercalated cells. Since angiotensin II increases pendrin-mediated Cl Ϫ absorption in vitro, we asked whether angiotensin II increases pendrin expression in vivo and whether angiotensin-induced hypertension is pendrin dependent. While blood pressure was similar in pendrin null and wild-type mice under basal conditions, following 2 wk of angiotensin II administration blood pressure was 31 mmHg lower in pendrin null than in wild-type mice. Thus pendrin null mice have a blunted pressor response to angiotensin II. Further experiments explored the effect of angiotensin on pendrin expression. Angiotensin II administration shifted pendrin label from the subapical space to the apical plasma membrane, independent of aldosterone. To explore the role of the angiotensin receptors in this response, pendrin abundance and subcellular distribution were examined in wild-type, angiotensin type 1a (Agtr1a) and type 2 receptor (Agtr2) null mice given 7 days of a NaCl-restricted diet (Ͻ 0.02% NaCl). Some mice received an Agtr1 inhibitor (candesartan) or vehicle. Both Agtr1a gene ablation and Agtr1 inhibitors shifted pendrin label from the apical plasma membrane to the subapical space, independent of the Agtr2 or nitric oxide (NO). However, Agtr1 ablation reduced pendrin protein abundance through the Agtr2 and NO. Thus angiotensin II-induced hypertension is pendrin dependent. Angiotensin II acts through the Agtr1a to shift pendrin from the subapical space to the apical plasma membrane. This Agtr1 action may be blunted by the Agtr2, which acts through NO to reduce pendrin protein abundance.
pendrin is upregulated with angiotensin II administration in vivo through receptor-dependent signaling.
The mouse kidney expresses multiple angiotensin II receptors (1a, 1b, and II) (9, 24) , although most of the renal tubular effects of angiotensin II on NaCl transport are mediated by the type 1a receptor (Agtr1a) (3) . In the absence of the Agtr1a (Agtr1a null mice), the pressor effect of angiotensin II is eliminated (13) , in part, from the absence of the Agtr1-dependent renal NaCl absorption. While the renal localization of the Agtr1 is controversial (9, 15) , functional studies have shown that angiotensin II applied in vitro regulates intercalated cellmediated transport through an Agtr1-dependent mechanism. For example, angiotensin II application in vitro increases pendrin-dependent Cl Ϫ absorption (27) and increases B cell apical Cl Ϫ /HCO 3 Ϫ exchange (38) . However, angiotensin II fails to stimulate apical anion exchange in the presence of an Agtr1 inhibitor (38) . Thus angiotensin II applied in vitro acts through the Agtr1 to modulate transport within type B intercalated cells. While pendrin-mediated transport is critical to the maintenance of blood pressure and apparent vascular volume in vivo during physiological activation of the renin-angiotensinaldosterone axis (36) , whether angiotensin II regulates pendrin expression in vivo, independent of aldosterone, is however unknown. Thus the purpose of this study was to determine 1) whether the hypertensive response to angiotensin II is pendrin dependent; 2) whether angiotensin II modulates pendrin expression in vivo, independently of aldosterone; and 3) whether angiotensin II modulates pendrin expression in vivo through an angiotensin receptor-mediated signaling event.
METHODS

Animals
Mice lacking the angiotensin type 1a receptor (Agtr1a null) were generated by homologous recombination in embryonic stem cells, as previously reported (13) . Mice were bred and maintained in the animal facility of the Veterans Administration Medical Center, Durham, NC and Emory University School of Medicine. We studied Agtr1a (ϩ/ϩ) and (Ϫ/Ϫ) littermates obtained from Agtr1a ϩ/Ϫ breeders that were F1 crosses of 129S6/SvEv ϫ C57BL/6. We compared Agtr2 null mice, described previously (12) , with age-and sex-matched wild-type mice on the same genetic background (C57BL/6). Pendrin null (7) and age-and sex-matched wild-type mice on the same genetic background (129S6SvEvTac) were compared as described previously (28) .
Animal Conditioning
Treatment 1: effect of angiotensin II on NaCl-replete mice. For 10 -14 days before euthanasia, mice were ration-fed a gelled diet (24.8% Zeigler Bros. 53881300 rodent chow, 74.6% water, 0.6% agar) supplemented with NaCl to give 0.8 meq/day NaCl or 1% NaCl (33) , while receiving angiotensin II (400 ng · kg body wt Ϫ1 · day Ϫ1 ) or vehicle by minipump.
Treatment 2: effect of angiotensin II on adrenalectomized NaClreplete mice. Mice were adrenalectomized and then received 2 wk of angiotensin II (400 ng · kg body wt Ϫ1 · day Ϫ1 ) or vehicle by minipump, while being ration-fed a gelled diet (24.8% Zeigler Bros. 53881300 rodent chow, 74.6% water, 0.6% agar) supplemented with NaCl to give 1 meq/day NaCl.
Treatment 3: effect of NaCl intake on wild-type and Agtr1a null mice. Mice were ration-fed a NaCl-deficient gelled diet for 7 days, using treatment models employed previously for the study of Agtr1a null mice (3). This gelled diet contained 27.1% diet (NaCl-deficient Harlan-Teklad diet, Ͻ0.02% NaCl), 72.4% H 2O, and 0.45% agar. Some mice received the same gelled diet but supplemented with NaCl (0.4% NaCl or 0.3 meq/day NaCl).
Treatment 4: effect of candesartan on NaCl-restricted mice. For 3 days, mice drank water ad libitum that contained 25 mg candesartan cilexetil (TCV-116)/l H 2O with 0.125% gum Arabic powder. For the next 4 days, mice received candesartan cilexetil (4 mg · kg body wt Ϫ1 · day Ϫ1 ) or vehicle in two divided doses by gavage while drinking H2O (without candesartan) ad libitum and were then euthanized. Throughout the treatment protocol, mice were ration-fed the NaCldeficient diet, described for treatment 3 (Harlan-Teklad), when given as pellets.
Treatment 5: effect of candesartan on NaCl-restricted, L-N
Gnitroarginine methyl ester-treated mice. Treatment 4 was repeated in mice that received L-N G -nitroarginine methyl ester (L-NAME) by minipump (mg · kg body wt Ϫ1 · day Ϫ1 ) over the 7-day treatment period. In mice, this dose of L-NAME produces NaCl-sensitive hypertension (14, 23) .
Treatment 6: effect of L-NAME on NaCl-restricted mice. Mice were given 7 days of the NaCl-deficient gelled diet described for treatment 3. For some mice, L-NAME was added to the diet to give 0.5 mg L-NAME/day. Other mice received diet and vehicle.
Measurement of Blood Pressure, Serum Aldosterone, and Arterial and Urinary pH and HCO 3
Ϫ Systolic blood pressure was measured in conscious mice by tail cuff using a BP-2000 (Visitech Systems). To condition mice for blood pressure readings, animals were placed in a platform for 15 min on 2 consecutive days. On the next 3-4 consecutive days, mice were placed on the platform and at least four readings were taken. All conditioning and all blood pressure readings were performed at the same location under quiet, low-light conditions. Measurements and conditioning were performed by the same operator at the same time of day. pH and PCO 2 were measured using an ABL5 analyzer (Radiometer America, Westlake, OH) in blood taken from the abdominal aorta. pH was measured in urine samples taken by bladder puncture. Serum aldosterone concentration was measured as described previously (36) .
All protocols were approved by the Animal Research Committees of the Durham Veterans Administration and Duke University Medical Centers and Emory University School of Medicine.
Antibody
For immunogold cytochemistry and immunohistochemistry, we employed a rabbit anti-pendrin antibody, characterized previously in mouse kidney studies (30) , that recognizes amino acids 766-780 of the human Slc26a4 protein sequence and specifically detects pendrin by immunogold cytochemistry (33) . Immunoblots were performed using a rabbit anti-rat pendrin antibody (20) , a generous gift of Dr. Peter Aronson, which recognizes the terminal 29 amino acids of the rat pendrin sequence and specifically detects mouse pendrin protein by immunoblotting (19) .
Immunohistochemistry
Kidneys were preserved by in vivo perfusion fixation and embedded in paraffin as described previously (19) . Pendrin immunoreactivity was detected using immunoperoxidase procedures; blocking was done with 3% H 2O2 in methanol for 30 min, followed by protein blocking using 1% Fig. 1 Wild-type mice given vehicle 11.6 Ϯ 0.8 (n ϭ 8) Wild-type mice given candesartan 11.8 Ϯ 2.8 (n ϭ 8) Agtr2 null mice given vehicle 13.9 Ϯ 1.5 (n ϭ 3) Agtr2 null mice given candesartan 12.4 Ϯ 0.9 (n ϭ 3) Effect of candesartan on L-NAME-treated wild-type mice (group 5) L-NAME 13.5 Ϯ 1.9 (n ϭ 5) L-NAME plus candesartan 9.5 Ϯ 1.4 (n ϭ 5) Effect of L-NAME on wild-type mice (group 6) Vehicle 7.87 Ϯ 1.26 (n ϭ 10) L-NAME 6.74 Ϯ 1.16 (n ϭ 10)
Values are means Ϯ SE. Agtr1, angiotensin type 1 receptor; L-NAME, L-N G -nitroarginine methyl ester. bovine serum albumin, 0.2% gelatin, 0.05% saponin solution; the antipendrin antibody was diluted 1:2,500 in PBS; the secondary antibody was a peroxidase-conjugated goat anti-rabbit IgG (DAKO).
Quantitative Analysis of Immunohistochemistry
Pendrin subcellular distribution was quantified as described previously in brightfield light micrographs (16) . High-resolution, digital micrographs were taken of defined tubular segments using a Nikon E600 microscope and a DXM1200F digital camera (36-megapixel images, ϫ40 objective) and ACT-1 software (Nikon) or a Leica DM2000 microscope and a Leica DFC425 digital camera (14.4-megapixel images, ϫ63 objective) and Leica DFC Twain Software and LAS application suite (Leica Microsystems, Buffalo Grove, IL). Pixel intensity across a line drawn from the tubule lumen through the center of an individual cell was quantified with National Institutes of Health ImageJ, version 1.34s software. The apical and the basolateral edges were determined as the point at which the intensity diverged from baseline. Initial experiments examining treatment 2 mice employed the Nikon microscope. In these studies, background pixel intensity was calculated as the mean pixel intensity outside the cell and was subtracted from the pixel intensity at each point. In later experiments, a Leica microscope was used and background pixel intensity was calculated as the mean pixel intensity in the basal 30% of the cell, where pendrin is not expressed, and subtracted from the pixel intensity at each point. Total cellular expression was determined by integrating net pixel intensity across the entire cell. Cell height was determined as the distance in pixels between the apical and the basolateral edges of the cell. Immunoreactivity expressed at the apical 10% of the cell was determined by integrating pixel intensity at this region. The individual performing the microscopy and quantifying the results was blinded as to the treatment group of each animal. Each value reported reflects the mean of measurements made in at least 10 tubules that were selected at random. Data from all cells from a given tubule segment, i.e., CCD or CNT, were averaged for each animal and used in the statistical analysis.
Immunogold Cytochemistry and Morphometric Analysis
Kidneys were prepared for electron microscopy as described previously (35) . Pendrin immunoreactivity was localized in ultrathin sections using immunogold cytochemistry (35) . Type A, type B, and non-A, non-B intercalated cell subtypes were identified using morphological characteristics established in studies of the mouse under basal conditions (35) . Apical plasma membrane boundary length, cytoplasmic area, and gold label that was touching the apical plasma membrane and gold label over the cytoplasm, including cytoplasmic vesicles, were quantified in type B and non-A, non-B intercalated cells as described previously (35) . In each animal, at least five cells of each intercalated cell subtype were selected at random and photographed at a primary magnification of ϫ5,000 and examined at a final magnification of approximately ϫ18,200. Raw morphometric data from individual cell profiles were pooled to generate an average value for each cell type for each animal. The "n" reported reflects the number of mice studied.
Statistical Analysis
For morphometric data without normal distribution or equal variance, a Mann-Whitney rank sum test was used. In all other studies, comparisons were made between two groups using an unpaired Student's t-test or among four groups using a two-way analysis of variance. A P Ͻ 0.05 indicates statistical significance. Data are displayed as means Ϯ SE. Values are means Ϯ SE. CNT, connecting tubule; CCD, cortical collecting duct. *P Ͻ 0.05, 2-tailed t-test. Fig. 4 . Genetic disruption of the angiotensin type 1a receptor (Agtr1a) blunts the effect of dietary NaCl restriction on pendrin subcellular distribution. This figure shows pendrin labeling in cortical sections taken from wild-type and Agtr1a null littermates (mixed C57BL6 and 129S6SvEv background) following 7 days of a NaCl-replete or a NaCl-deficient diet (treatment 3). Arrows identify cells with prominent, discrete labeling in the region of the apical plasma membrane. In wild-type mice, a low-salt diet increases the number of intercalated cells within the CNT that have discrete apical pendrin immunolabel. In Agtr1a null mice fed a low-salt diet, few intercalated cells have this discrete apical pendrin immunolabel.
RESULTS
Hypertensive Response to Angiotensin II is Pendrin Dependent
Since angiotensin II applied in vitro increases pendrinmediated Cl Ϫ absorption in the CCD (27), we asked whether the hypertensive response to angiotensin II administered in vivo is pendrin dependent. To answer this question, blood pressure was measured in adrenal-intact wild-type and pendrin null mice given angiotensin II or vehicle for 2 wk while consuming a NaCl-replete diet (treatment 1, Fig. 1 ). Following an angiotensin II infusion, both circulating angiotensin II and renal angiotensin II content should increase (6, 25) . When mice were given the NaCl-replete diet and vehicle, blood pressure did not differ between vehicle-treated pendrin null and wildtype mice [wild-type mice 125 Ϯ 4, n ϭ 3; pendrin null mice, 121 Ϯ 9 mmHg, n ϭ 4, P ϭ not significant (NS)], as observed previously (33) . However, in separate mice given 2 wk of the NaCl-replete diet and angiotensin II (treatment 1), blood pressure was 31 mmHg lower ( Fig. 1) in the pendrin null than in wild-type mice (wild type mice 154 Ϯ 7, n ϭ 10; pendrin null mice 123 Ϯ 9 mmHg, n ϭ 10, P Ͻ 0.05). However, circulating aldosterone concentration was similar in the angiotensin IItreated mutant and wild-type mice (Table 1) . Thus pendrin null mice have a blunted hypertensive response to angiotensin II.
Pendrin Subcellular Distribution Is Regulated by Angiotensin II
Further studies asked whether pendrin abundance increases with angiotensin II treatment. Thus we examined pendrin labeling in cortical sections from mice given a NaCl-replete diet and either an infusion of angiotensin II or vehicle. As shown (Fig. 2) , in both the CNT and the CCD, pendrin immunolabel in the region of the Fig. 6 . During NaCl restriction, pendrin protein abundance and apical plasma membrane pendrin immunolabel are lower in kidneys from Agtr1a null than in wild-type mice. Agtr1a null and wild-type littermates (C57BL6 background) were given 7 days of a NaCl-deficient diet (treatment 3). The ratio of pendrin label on the apical plasma membrane relative to the cytoplasm (A) and pendrin label per cell (B) were quantified in type B and non-A, non-B cells using immunogold cytochemistry with morphometric analysis. apical plasma membrane appeared more intense and discrete in mice that received angiotensin II relative to those receiving vehicle, consistent with increased apical plasma membrane pendrin immunolabel. However, pendrin protein abundance was similar in renal lysates from mice receiving angiotensin II and those receiving vehicle (Fig. 2) . Thus angiotensin II administration in vivo shifts pendrin immunolabel from the subapical space to the apical plasma membrane, without altering global renal pendrin abundance.
Because angiotensin II increases aldosterone production (39) and because aldosterone increases apical plasma membrane pendrin expression (33), we hypothesized that angiotensin II increases pendrin expression due to increased aldosterone production. To test this hypothesis, wild-type mice were adrenalectomized and then divided into two groups. One group received 2 wk of angiotensin II and a NaCl-replete diet, while the other received the diet and vehicle (treatment 2). Serum aldosterone was extremely low in these adrenalectomized mice whether they received angiotensin II or vehicle (Table 1) (22) . However, angiotensin II treatment increased systolic blood pressure by ϳ50 mmHg (Fig. 3A) . Angiotensin II also increased apical plasma membrane pendrin label in the CNT by 44% (Table 2, Fig. 3B ). However, this hormone did not alter pendrin subcellular distribution in the CCD (Table 2 , Fig. 3B ) and did not alter renal pendrin protein abundance (Table 2, Fig. 3, C and D) . We conclude that angiotensin II induces a shift in pendrin immunolabel in the CNT from the subcellular space to the apical plasma membrane through an aldosterone-independent mechanism.
Pendrin Protein Abundance and Subcellular Distribution Are Regulated by the Agtr1a
Because most of the biological effects of angiotensin II are mediated by the Agtr1a (3), further experiments asked whether pendrin is regulated by the Agtr1a. Thus pendrin expression was examined in wild-type and Agtr1a null mice. These mice were given a NaCl-replete or a NaCl-restricted diet (treatment 3), since angiotensin II production increases with NaCl-restriction and falls with NaCl intake (6). As shown (Fig. 4) , in CNTs from wild-type mice the number of pendrin-positive cells with discrete immunolabel in the region of the apical plasma membrane appears more prominent in the NaCl-restricted mice. To determine whether the Agtr1a null mice have a blunted increment in apical plasma membrane pendrin immunolabel following NaCl restriction, immunogold cytochemistry with morphometric analysis was employed to quantify the effect of genetic disruption of the Agtr1a on pendrin total protein abundance and subcellular distribution during NaCl restriction. As shown (Figs. 5 and 6A, Table 3 ), the fraction of pendrin label in the apical plasma membrane relative to cytoplasm was lower in non-A, non-B intercalated cells from Agtr1a null mice than in wild-type mice, although pendrin protein abundance was similar in non-A, non-B cells from mutant and wild-type mice. In contrast, B cells from NaCl-restricted Agtr1a null mice have lower pendrin protein abundance relative to wildtype mice (Fig. 6B, Table 3 ), although the apical distribution fraction was the same in B cells from the mutant and wild-type mice (Fig. 6A, Table 3 ).
Genetic disruption of the Agtr1a increases circulating aldosterone (3), which should increase pendrin protein abundance and increase the fraction of pendrin expressed in the apical plasma membrane relative to the cytoplasm (33). However, since pendrin expression is reduced in the Agtr1a kidney (Fig.  6, Table 3 ), Agtr1a gene ablation does not alter pendrin expression through changes in circulating aldosterone concentration.
Because pendrin mediates secretion of OH Ϫ equivalents, arterial and urinary pH were measured in wild-type and Agtr1a null mice following 7 days of dietary NaCl restriction (Table 4) . Urinary pH was lower in the Agtr1a null relative to wild-type mice consistent with reduced pendrin expression in the mutant mice (33, 36). 1 1 Agtr1a null mice had a lower PCO2 and higher arterial pH than wild-type mice. The cause of this respiratory alkalosis is unclear since PO2 was similar in both groups (480 Ϯ 89 mmHg, n ϭ 6, wild-type; 396 Ϯ 92, n ϭ 5, Agtr1a null, P ϭ not significant). 
Pendrin Subcellular Distribution Is Regulated by the Agtr1 But Not by the Agtr2
Further studies asked whether chemical Agtr1 inhibitors modulate pendrin subcellular distribution. Thus mice were treated with an Agtr1a/Agtr1b blocker (candesartan). As shown, candesartan shifted pendrin subcellular distribution from the region of the apical plasma membrane to the subapical space (Fig. 7, Table 5 ). Candesartan does not reduce pendrin expression by reducing circulating angiotensin II or aldosterone concentration, since circulating angiotensin II (6) and aldosterone concentration (Table 1) should be the same or increased in this treatment model. We conclude that either genetic ablation of the Agtr1a or chemical Agtr1 inhibitors reduce apical plasma membrane pendrin abundance.
Since inhibiting the Agtr1 unmasks Agtr2 action (1), we asked whether inhibiting the Agtr1 reduces pendrin abundance from a compensatory increase in Agtr2 action. If so, genetic disruption of the Agtr2 should eliminate candesartan-induced changes in pendrin expression. To answer this question, we explored the effect of Agtr1 inhibition on pendrin subcellular distribution in wild-type and in Agtr2 null mice. As shown (Fig. 7, Table 5 ), in both Fig. 7 . Candesartan reduces pendrin immunolabel in the region of the apical plasma membrane in the CNT of both wild-type and in Agtr2 null mice. Wild-type and Agtr2 null mice (C57BL6 background) were given 7 days of the NaCl-deficient diet and either candesartan or vehicle (treatment 4). Pendrin immunolabel is displayed in sections taken from the cortical labyrinth of mice from each group (A-D). A=-D= show the area in the box displayed in the panel above at higher power. In both genotypes, vehicle-treated mice have discrete apical pendrin immunolabel (A= and B=), whereas more diffuse labeling is seen after candesartan treatment (C= and D=).
wild-type and Agtr2 null mice candesartan treatment reduced blood pressure and shifted pendrin subcellular distribution in the CNT from the region of the apical plasma membrane to the subapical space. Thus the Agtr1 alters pendrin subcellular distribution independent of the Agtr2.
Pendrin Protein Abundance Is Regulated by the Agtr2
Further experiments explored whether the changes in pendrin protein abundance observed with Agtr1 ablation are Agtr2 dependent. Although circulating aldosterone concentration was similar in mice given candesartan or vehicle (Table 1) , Agtr1 inhibition reduced pendrin abundance in renal lysates from wild-type mice but had no effect in the Agtr2 null kidney (Fig. 8) . We conclude that Agtr1 inhibitors reduce pendrin protein abundance through an Agtr2-dependent, aldosterone-independent mechanism.
Inhibiting Nitrix Oxide Synthase Blunts the Fall in Pendrin Protein Expression Observed with Agtr1 Inhibition, But Does Not Alter Effect of Agtr1 Inhibitors on Pendrin Subcellular Distribution
Because Agtr2 action occurs largely through nitric oxide (NO) (1, 5), we asked whether NO blockade alters the effect of Agtr1 inhibitors on pendrin protein abundance and/or subcellular distribution. To answer this question, mice were given the NO synthase inhibitor, L-NAME or L-NAME and candesartan. As shown (Fig. 9, Table 6 ), in L-NAME-treated mice candesartan administration shifted pendrin label in the CNT from the region of the apical plasma membrane to the subapical space. Because blocking NO synthase did not prevent the subcellular redistribution observed with Agtr1 inhibition (Table 1) , the Agtr1 alters pendrin subcellular distribution independent of NO. However, L-NAME treatment eliminated the fall in pendrin total protein abundance observed with Agtr1 blockade (Fig. 9 , E and F). We conclude that Agtr1-dependent changes in pendrin protein abundance are dependent on renal cortical NO.
Inhibiting NO Synthase Increases Pendrin Protein Abundance
Further studies asked whether NO synthase inhibition alters pendrin protein abundance. Thus mice received a NaCl-deficient diet and L-NAME or diet and vehicle for 7 days. As expected, systolic blood pressure was ϳ20 mmHg higher in the L-NAMEthan in the vehicle-treated mice (Fig. 10A) . Moreover, L-NAME administration increased pendrin protein abundance by ϳ15% (Fig. 10, B and C) . Table 1 shows that the increase in pendrin abundance observed in L-NAME-treated mice does not occur from increased circulating aldosterone concentration. However, Fig. 11 demonstrates that L-NAME does not produce a large change in pendrin subcellular distribution. We conclude that inhibiting NO synthase increases blood pressure and pendrin protein abundance through an aldosterone-independent mechanism.
DISCUSSION
Angiotensin II is a powerful modulator of NaCl absorption in the kidney (21) . This vasoactive hormone acts through the Agtr1a to stimulate the expression and function of the thiazidesensitive NaCl cotransporter and the epithelial sodium channel, Fig. 9 . Candesartan does not reduce pendrin total protein abundance in L-N G -nitroarginine methyl ester (L-NAME)-treated wild-type mice but reduces apical pendrin localization. Wild-type mice on a C57BL6 background were given the NaCl-restricted diet and L-NAME or L-NAME and candesartan (treatment 5). Pendrin labeling in cortical sections from mice in each group is displayed (left). A and B: pendrin label at low power. The areas marked in each box display pendrin labeling at higher power (A= and B=, CNT). C and D: pendrin label in CCDs from mice in each treatment group. E: representative gel loaded with kidney lysates from mice in each group and probed for pendrin. F: pendrin band density in renal lysates from mice in each group. Values are means Ϯ SE. The experiments given above were done in 129 S6SvEvTac mice. However, similar results were observed in C57BL6 mice (n ϭ 2/group, not shown). *P Ͻ 0.05, 2-tailed Student's t-test.
ENaC, both in vivo and in vitro (2, 3) . The result is expansion of vascular volume and increased blood pressure. The present study demonstrates that angiotensin II also acts through the Agtr1a to shift pendrin subcellular localization from the subapical space to the apical plasma membrane, which probably contributes to the hypertensive effect of this hormone.
This study also shows that the pressor response to angiotensin II is dependent on pendrin expression. The blunted pressor response observed in pendrin null mice occurs in part from the absence of pendrin-mediated Cl Ϫ absorption (27) . However, since pendrin modulates ENaC abundance and function (18, 28) , pendrin gene ablation may also blunt the increment in ENaC abundance observed with angiotensin II administration (2, 3), thereby reducing the increment in Na ϩ absorption (27) and the volume expansion expected with administration of this hormone. NaCl restriction was employed as a treatment model in which angiotensin II release is appropriately increased. During NaCl restriction, we observed that Agtr1 blockade produces very cell type-specific effects on pendrin expression and cellular signaling. Both chemical inhibitors of the Agtr1 and genetic ablation of the Agtr1a alter pendrin subcellular distribution more in the CNT than in the CCD. In particular, ablation of the Agtr1a shifts pendrin subcellular distribution away from the apical plasma membrane in non-A, non-B intercalated cells, which localize primarily to the CNT and iCT (35) but does not change pendrin subcellular distribution in B cells, which are mostly found in the iCT and CCD (35) . In contrast, Agtr1a gene ablation reduces pendrin Fig. 10 . L-NAME increases pendrin protein abundance. Mice on a 129 S6SvEv Tac background were given the NaCldeficient diet or diet and L-NAME (0.5 mg/day) for 7 days (treatment 6) and then euthanized. A: systolic blood pressure measured in mice from each group. B: pendrin band density in immunoblots loaded with kidney lysates taken from mice from each group. C: representative gel probed for pendrin. Fig. 11 . Effect of L-NAME on pendrin label distribution. Mice were given L-NAME or vehicle for 7 days (treatment 6), as described in Fig. 10 and then euthanized. Sections of kidney cortex taken from mice in each group were labeled for pendrin.
protein abundance in B cells, although protein abundance is unchanged in non-A, non-B cells.
Aldosterone treatment also changes pendrin protein abundance and subcellular distribution, but by targeting opposite intercalated cell subtypes. In contrast to the effect of the angiotensin II acting through the Agtr1a, aldosterone analogs change pendrin subcellular distribution much more in type B than in non-A, non-B intercalated cells (33) , but change pendrin protein abundance more in non-A, non-B than in type B cells (33) .
Since Agtr1a protein expression and function have been detected in intercalated cells (15, 27, 38) , angiotensin II might modulate pendrin subcellular distribution through a direct effect on the Agtr1a in type B and/or non-A, non-B intercalated cells. However, we cannot exclude the possibility that angiotensin II acts on Agtr1a receptors in other cell types, which increases pendrin abundance through an endocrine or paracrine effect or through a cell-cell interaction. For example, Guzik et al. (8) observed that the pressor response to angiotensin II was markedly attenuated in mice lacking T lymphocytes. While adoptive transfer of T cells from wild-type mice fully restored the pressor response to angiotensin II, this pressor response was only partially restored with adoptive transfer of T cells from Agtr1a null mice. Therefore, angiotensin II may act on the Agtr1a in T cells, which increases cytokine release (8) , thereby changing pendrin subcellular distribution and abundance within intercalated cells.
The Agtr1a most likely acts downstream of angiotensin II to modulate pendrin expression. 2 In other cell types, angiotensin II acts through the Agtr1a to mediate its biological effects through many downstream signaling pathways (11) . The signaling pathway(s) that act downstream of the Agtr1a to mediate this change in pendrin subcellular distribution remain to be determined.
The present study shows that the Agtr2 and Agtr1 may have opposing effects on pendrin expression. With Agtr1 inhibition, a compensatory increase in Agtr2 mRNA and protein abundance is observed (32) . Moreover, Agtr1 blockade increases Agtr2-dependent NO production in the renal cortex of NaClrestricted mice (1) . Since Agtr1 inhibition reduces pendrin protein abundance through an Agtr2-and NO-dependent mechanism 3 , Agtr1 inhibition may reduce pendrin abundance by increasing Agtr2 expression and function, which increases NO production. Whether NO has a direct effect on renal pendrin total protein abundance remains to be determined in the future in vitro studies.
We conclude that the hypertensive response to angiotensin II occurs through a receptor-mediated process that is pendrin dependent. Administration of angiotensin II in vivo shifts pendrin subcellular distribution from the subapical space to the apical plasma membrane, independent of aldosterone. During dietary NaCl restriction, the Agtr1a modulates pendrin total protein abundance and subcellular distribution through distinct, cell type-specific mechanisms. Upon stimulation by angiotensin II, the Agtr1a acts independently of the Agtr2 to shift pendrin expression from the subapical space to the apical plasma membrane in non-A, non-B intercalated cells, which likely contributes to the hypertensive response observed with angiotensin II treatment. However, the pressor response to angiotensin II is probably blunted, in part, by activation of the Agtr2 (5), which increases renal cortical NO, thereby reducing pendrin total protein abundance.
